Skip to content

Validation of the Wisconsin Stone-QOL

Validation of the Wisconsin Stone-QOL, a Quality of Life Survey for Kidney Stone Formers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02188108
Enrollment
3299
Registered
2014-07-11
Start date
2014-07-31
Completion date
2023-06-30
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stones, Nephrolithiasis, Urolithiasis

Keywords

quality of life, QOL, urolithiasis, nephrolithiasis, kidney stones, patient-reported outcomes

Brief summary

The overall purpose of this study is to evaluate criterion-related validity of a newly-developed disease-specific instrument to assess the health-related quality of life (HRQOL) of patients who have had kidney stones. Specific aims of this study are: 1. Aim 1. Evaluate the population/external validity (generalizability) of the Wisconsin Stone-QOL by answering the question, Is the Wisconsin Stone-QOL useful for assessing the HRQOL of patients who form kidney stones from a broad region of North America? 2. Aim 2. Assess the ability of the Wisconsin Stone-QOL to detect changes within patients related to stone interventions and other disease-specific outcomes by answering the question, Is the Wisconsin Stone-QOL sensitive to changes in stone-related outcomes within individuals?

Detailed description

The Wisconsin Stone-QOL was developed as the only known HRQOL instrument designed specifically for patients with kidney stones. Its development has been published. Internal and other validity tests on the instrument have been conducted and reported. Further validity testing of the instrument is needed to confirm its broader utility in the context of surgical and medical management of patients with kidney stones. Upon enrollment at each site, patients will be asked to complete a medical history form and the Wisconsin Stone-QOL. To supplement the information provided in the medical history forms, patients' medical records will be reviewed in order to collect and enter approved data into a spreadsheet. Further patient interventions include completion of the Wisconsin Stone-QOL at 3 months, 12 months, 24 months, and 36 months post-enrollment. These post-enrollment surveys will usually be mailed to patients to the addresses they provide. Alternatively, patients may be provided the surveys at a urology encounter if it falls on or near the intervention time points. At each time point, patients' medical records will also be searched to document any changes in the data entered at enrollment.

Interventions

OTHERWisconsin Stone-QOL survey

Patients will complete a health-related quality of life survey at multiple time points at enrollment and at multiple time points thereafter.

Sponsors

University of Florida
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
University of North Carolina
CollaboratorOTHER
Dartmouth College
CollaboratorOTHER
The Cleveland Clinic
CollaboratorOTHER
University of British Columbia
CollaboratorOTHER
University of Texas
CollaboratorOTHER
University of California, Davis
CollaboratorOTHER
University of California, Irvine
CollaboratorOTHER
University of California, San Francisco
CollaboratorOTHER
University of Washington
CollaboratorOTHER
Penn State University
CollaboratorOTHER
McGill University
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
Université de Montréal
CollaboratorOTHER
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of kidney stones, either in the past or currently * 18 years of age or older

Exclusion criteria

* Under 18 years of age * No previous or current diagnosis of kidney stones

Design outcomes

Primary

MeasureTime frameDescription
Patients' self-reported health-related quality of life (HRQOL)EnrollmentChange in HRQOL from baseline to follow-up time points will be assessed

Secondary

MeasureTime frame
Patients' self-reported quality of life3 months

Other

MeasureTime frame
Patients' self-reported quality of life12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026